Enabling the promise of Stem Cells. Spring 11 By Robert Shaw and Dr Jeff Till The remarkable potential of stem cells to generate several hundred differentiated cell types is driving their use for regenerative medicine and for supporting the traditional drug discove... Read more...

Making Early Access Real: getting treatments to patients with no other option. Winter 10 By Dr Rav Seeruthun For patients who have no other option to treat their condition, early access to drugs in clinical development can be critical. As a trained physician, there is an intrinsic understanding ... Read more...

New ways to optimise therapeutic and diagnostic antibodies. Winter 10 By Dr Markus Enzelberger Monoclonal antibodies are the fastest-growing category of research within the biotech and pharmaceutical industries. Several monoclonal antibodies are listed in the top 10 selling blockbu... Read more...

New mechanisms and expanded indications for biologic therapies: a perspective on immunology research and development. Fall 10 By Dr Susan B. Dillon Over the past decade, the introduction of biologic therapies has had a profound impact for millions of patients with immune-mediated arthritides, inflammatory bowel diseases and plaque ps... Read more...

New trends and therapeutic approaches for the management of diabetic retinopathy. Summer 10 By Dr Didier Pruneau Diabetes mellitus is a growing epidemic that has become a global public health problem. The long-term complications of diabetes include retinopathy, the leading cause of blindness and vis... Read more...

Stem Cells for cellular therapy space. Spring 10 By Dr Enal S. Razvi and Dr Gary M. Oosta This article explores the emerging market landscape vis-à-vis the use of stem cells as cellular therapeutics. For more than 40 years, hematopoietic stem cells have been utilised as cellu... Read more...